Conference coverage
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
12/11/2000
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies—which do not include 5-ASAs— to help prevent complications and change the natural history of their disease.
Marla Dubinsky, MD, is a professor of Pediatrics and Medicine (Gastroenterology) at the Icahn School of Medicine and chief of Division of Pediatric Gastroenterology at Mount Sinai Kravis Children's Hospital in New York, New York.